50 /100
MEDIUM RISK
Score updated May 28, 2026

JAGX — Jaguar Health, Inc. Dilution Risk Tracker

Track JAGX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track JAGX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
30%
🔁 Convertible Conversion 60%
• Major convertible overhang: 508% potential dilution
• Convertible risk score very high (85/100)
🔔 Track JAGX — Get forecast alerts →

💹 Market Data

Market Cap$2.10M
Shares Outstanding657.4K
Float572.0K
Cash$7.28M
Debt$34.31M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 31.6% shares (2025Q4 vs prior)
12 institutional holders · 66.1K shares
#1 GEODE CAPITAL MANAGEMENT, LLC 24.0K shares
#2 DRW Securities, LLC 17.8K shares
#3 XTX Topco Ltd 12.5K shares
+ 9 more holders Sign up free to view →

📉 Short Interest

Short Interest107.5K
Days to Cover5.5
% of Float18.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2025
8-K 8K EVENT May 04, 2026
8-K 8K EVENT Apr 21, 2026
4 INSIDER TRANSACTION Mar 12, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track JAGX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking JAGX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for JAGX
📊 JAGX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 JAGX Signal Convergence & Dark Pool Activity — StonkWhisper 📄 JAGX Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.